Treatment of a Metastatic Prostate Derived Tumor with Surgery and Chemotherapy
- 1 June 1982
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 127 (6) , 1238-1242
- https://doi.org/10.1016/s0022-5347(17)54306-2
Abstract
The R3327/MAT-Lu tumor is a metastasizing variant of the Dunning R3327 Copenhagen rat prostatic carcinoma which, when implanted s.c. in the flank or i.m. in the hind leg, invariably metastasizes to the lungs. Treatment with single dose chemotherapy, surgical excision of the primary tumor or a combination of tumor excision and postperative single dose chemotherapy was examined. All 3 regimes significantly reduced the number of lung metastases, but only the combination of tumor excision followed by postoperative chemotherapy substantially prolonged survival and produced cures.This publication has 9 references indexed in Scilit:
- Effect of high dose diethylstilbestrol and ICRF-159 on the growth and metastases of the R3327 MAT-LyLu prostate-derived tumorCancer Letters, 1981
- Multimodal treatment in operable breast cancer: five-year results of the CMF programme.BMJ, 1981
- Interference with in vivo growth and metastasis of prostate adenocarcinoma (PA-III) by ICRF-159The Prostate, 1981
- Surgical adjuvant chemotherapy of metastatic murine osteosarcomaInternational Journal of Cancer, 1980
- Surgical adjuvant chemotherapy of metastatic murine tumorsCancer, 1977
- TUMOR SIZE, SENSITIVITY TO THERAPY, AND DESIGN OF TREATMENT SCHEDULES1977
- The treatment of Wilms' tumor. Results of the national Wilms' tumor studyCancer, 1976
- Concepts for systemic treatment of micrometastasesCancer, 1975
- THE SIGNED-RANK (WILCOXON) TESTThe Lancet, 1969